• Skip to main content
  • Skip to primary navigation
  • Home
  • Community Schedule
  • Hospital Medicines (HML)
  • Medicine funding application status

Pharmac - Te Pātaka Whaioranga. Pharmac - Te Pātaka Whaioranga. Pharmac - Te Pātaka Whaioranga.

  • Pharmaceutical Schedule Te Rārangi Rongoā

    Pharmaceutical Schedule

    All funded medicines in New Zealand.

    • Community Schedule

    • Practitioners supply order (PSO)

    • Extemporaneously compounded products and galenicals

    • Hospital Medicines (HML)

    • Ambulance Medicines List (Section E)

      Medicines funded for ambulance services

    • PRIME services, lead maternity carers, and palliative care can access more medicines

      Emergency medicines available where they're needed.

    • Schedule Updates

    • Schedule resources

    • About the Schedule

    • Rules of the Schedule

    • Hospital Medical Devices

    • Redevelopment of the Schedule

  • Funding medicines Ngā umanga rongoā

    Funding medicines

    • Make an application

    • From application to funded medicine: Pharmac's process

      Follow the journey of a funding application

    • Medicines budget

      The law requires PHARMAC to stay within its budget

    • Prioritisation

      How we decide which medicines need funding first

    • Procurement processes

      Some of the ways Pharmac uses to fund products for New Zealanders.

    • Labelling preferences for medicines

      Label layout for medicines in New Zealand

    • Declining inactive funding applications

      Pharmac's process.

    • Policies, manuals and processes

      The guides we use when we make decisions

  • About medicine supply Ngā umanga rongoā

    About medicine supply

    Ask us to fund a medicine | Check changes to medicines | How do generics work?

    • Supply issues and updates

      Brand changes, discontinuations and more.

    • ADHD treatments

      Changes are happening to how ADHD treatments are managed in New Zealand.

    • Antiretroviral medicine changes

    • Continuous glucose monitors and insulin pumps

    • COVID-19 antiviral treatments

      Information on who can get funded access to COVID-19 antivirals.

    • Generic medicines

      Generics work the same way

    • 12-month prescriptions

    • Ordering bulk condoms

      Information for community health organisations

    • Ordering nicotine replacement therapy (NRT) products

      Information for authorised providers

    • Guide for medicine and medical device suppliers working with Pharmac

    • Collecting and paying for medicines

      Answering your questions about prescriptions

    • Managing medicine supply

      How PHARMAC works with suppliers on supply

  • Hospital medical devices Ngā pūrere hauora a te hōhipere

    Hospital medical devices

    • The future of managing hospital medical devices

    • New and emerging medical device technologies

    • Hospital Medical Devices Programme

    • Hospital Medical Devices List

      Download the latest hospital medical devices schedule

    • Pharmac-Health NZ Medical Devices Supplier Reference Group

    • Stay in touch

      How to learn the latest about our work.

  • News and resources Ngā karere me ngā rauemi

    News and resources

    • Consultations and decisions

      includes RFPs and tenders.

    • News, stories, and updates

    • Official information releases

      How to make an OIA or Privacy Act request and find information Pharmac has already released.

    • Publications and resources

    • Exceptional Circumstances Framework Review

      Pharmac is reviewing its Exceptional Circumstances Framework to make it simpler and clearer to better meet the needs of people who rely on it to get funded access to medicines.

    • ADHD treatments

      Changes are happening to how ADHD treatments are managed in New Zealand.

    • Pharmac's research

    • PRIME services, lead maternity carers, and palliative care can access more medicines

      Emergency medicines available where they're needed.

  • About Mō Te Pātaka Whaioranga

    About

    • Strategic Direction

      Our plan to deliver the best health outcomes for New Zealanders

    • Timely Assessment Programme (TAP)

    • What we do

    • Who we are

    • How we get advice

      Advice we seek to make decisions

    • Working at Pharmac

      Explore current vacancies

    • Contact us

      How to get in touch

  1. Home
  2. About medicine supply
  3. COVID-19 antiviral treatments

COVID-19 antiviral treatments

Information on who can get funded access to COVID-19 antivirals.

  • COVID-19 antivirals access criteria (includes Paxlovid)

    Access criteria for nirmatrelvir with ritonavir (Paxlovid), and remdesivir (Veklury)

  • Paxlovid (COVID-19 antiviral) access criteria assessment tool

  • Identifying people at high risk for severe illness from COVID-19

  • Severely immunocompromised for access to COVID-19 antiviral treatments

  • Remdesivir: access criteria for COVID-19 treatment in hospitalised patients

  • Remdesivir (Veklury) - hospital access criteria assessment tool

  • Access criteria for treatments for persistent SARS-CoV-2 infection

Back to top

Pharmac - Te Pātaka Whaioranga.

  • Community Schedule
  • Hospital Medicines (HML)
  • Application Tracker
  • Contact us
  • Follow us
  • Facebook
  • LinkedIn

Shielded site.

  • Copyright
  • Disclaimer
  • Privacy statement
  • Subscribe
  • Media centre

New Zealand Government.